Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dense Breast Tissue”

130 trials

Showing 20 of 130 results

Not applicableStudy completedNCT00620373
What this trial is testing

Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts

Who this might be right for
Breast Cancer
Mayo Clinic 969
Not applicableUnknownNCT02066142
What this trial is testing

Tomosynthesis (TS) Versus Ultrasonography (US) in Women With Dense Breast

Who this might be right for
Breast Cancer
University of Genova 4,000
Not applicableEnrolling By InvitationNCT06836089
What this trial is testing

DWI Breast MRI in Dense Breast: A Clinical Trial to Assess the Efficacy and Diagnostic Accuracy of Diffusion Weighted Imaging in Dense Breast Tissue

Who this might be right for
Dense Breast ParenchymaBreast Cancer DetectionDWI
Graziella di Grezia 350
Not applicableActive Not RecruitingNCT03607552
What this trial is testing

Non-contrast DWI for Supplemental Screening

Who this might be right for
Breast Cancer
University of Washington 269
Not applicableStudy completedNCT00816530
What this trial is testing

A Clinical Study to Evaluate Somo•v and Digital Mammography Together as a Breast Cancer Screening Method, Compared to Digital Mammography Alone, in Women With Dense Breasts.

Who this might be right for
Breast Cancer
U-Systems, Inc. 15,679
Not applicableActive Not RecruitingNCT04854304
What this trial is testing

Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts

Who this might be right for
Breast Diseases
Abramson Cancer Center at Penn Medicine 500
Testing effectiveness (Phase 2)Study completedNCT03575520
What this trial is testing

Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients

Who this might be right for
Breast Cancer
Yonsei University 63
Testing effectiveness (Phase 2)Ended earlyNCT01194869
What this trial is testing

Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Emory University 25
Large-scale testing (Phase 3)Ended earlyNCT03199963
What this trial is testing

Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue

Who this might be right for
Mammographic Breast Density
BHR Pharma, LLC 223
Testing effectiveness (Phase 2)Study completedNCT01671319
What this trial is testing

Dose Dense TC + Pegfilgrastim Support for Breast Cancer

Who this might be right for
Female Breast Cancer
University of Wisconsin, Madison 42
Not applicableUnknownNCT03033030
What this trial is testing

Tomosynthesis (TS) or Ultrasound (US) in Mammography-negative Dense Breasts (TOMUS). National Multicenter Trial

Who this might be right for
Breast Cancer
University of Genova 8,000
Large-scale testing (Phase 3)Study completedNCT01690702
What this trial is testing

Study of Nab-Paclitaxel in High Risk Early Breast Cancer

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 2,886
Testing effectiveness (Phase 2)UnknownNCT02595320
What this trial is testing

Capecitabine in Metastatic Breast and GI Cancers

Who this might be right for
Breast CancerGastrointestinal Cancer
Qamar Khan 200
Not applicableStudy completedNCT02527317
What this trial is testing

Dose Dense Chemotherapy With Lipegfilgrastim Support in Early Breast Cancer

Who this might be right for
Breast Cancer
Beaumont Hospital 40
Not applicableUnknownNCT02506361
What this trial is testing

Evaluation of the Relationship of TOP2α Expression and Effect of Non Dose-dense Chemotherapy for Breast Cancer

Who this might be right for
Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 800
Not applicableStudy completedNCT00617370
What this trial is testing

Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility

Who this might be right for
Breast CancerAdenocarcinoma of the Breast
Memorial Sloan Kettering Cancer Center 38
Testing effectiveness (Phase 2)Study completedNCT00591851
What this trial is testing

Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide (AC) Followed By Paclitaxel With Trastuzumab in HER2/ NEU-Amplified Breast Cancer: Feasibility

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 70
Large-scale testing (Phase 3)Study completedNCT01985724
What this trial is testing

Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer

Who this might be right for
Breast Cancer
Hellenic Oncology Research Group 650
Testing effectiveness (Phase 2)Study completedNCT00270894
What this trial is testing

Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients

Who this might be right for
Breast Neoplasm
Accelerated Community Oncology Research Network 30
Very early researchStudy completedNCT00722059
What this trial is testing

Detection and/or Evaluation of Dense Breast Abnormalities Using Tomosynthesis and Digital Mammography

Who this might be right for
Breast NeoplasmsBreast Abnormalities
University of Michigan 50
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation